Cystic Fibrosis – Symptoms, causes, diagnosis & treatment

What is Cystic Fibrosis? Cystic fibrosis (CF) is a genetic disorder that primarily affects the lungs and digestive system. It leads to the production of thick, sticky mucus that clogs the airways and obstructs the pancreas, causing respiratory and digestive complications. CF is a chronic condition that requires lifelong management and care.

Types of Cystic Fibrosis: Cystic fibrosis can present with a wide range of symptoms and severity, depending on the specific mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Common types of CF include:

  1. Classical CF: Characterized by typical respiratory and digestive symptoms.
  2. Non-classical CF: May present with milder symptoms or affect only one organ system.

Symptoms of Cystic Fibrosis: Common symptoms of cystic fibrosis include:

  • Persistent cough with thick, sticky mucus.
  • Frequent lung infections, such as pneumonia or bronchitis.
  • Shortness of breath and wheezing.
  • Poor growth and weight gain despite a good appetite.
  • Chronic sinus infections.
  • Salty-tasting skin.
  • Greasy or bulky stools.
  • Difficulty digesting food and absorbing nutrients.

Causes of Cystic Fibrosis: Cystic fibrosis is caused by mutations in the CFTR gene, which regulates the movement of salt and water in and out of cells. These mutations lead to the production of thick, sticky mucus in various organs, particularly the lungs and pancreas.

Risk Factors for Cystic Fibrosis: The most significant risk factor for cystic fibrosis is having a family history of the condition. Cystic fibrosis is an autosomal recessive disorder, meaning that both parents must carry a copy of the faulty CFTR gene for their child to inherit the condition.

Diagnosis of Cystic Fibrosis: Diagnosis of cystic fibrosis typically involves a combination of medical history, physical examination, and diagnostic tests:

  • Newborn screening: Most cases of cystic fibrosis are diagnosed through newborn screening programs that test for elevated levels of immunoreactive trypsinogen (IRT) in the blood.
  • Sweat test: A sweat test measures the concentration of salt (chloride) in sweat, which is typically elevated in individuals with cystic fibrosis.
  • Genetic testing: Genetic testing can identify specific mutations in the CFTR gene associated with cystic fibrosis.

Pharmacokinetics and Pharmacodynamics: Pharmacological treatment for cystic fibrosis aims to alleviate symptoms, prevent complications, and improve quality of life. These medications may vary in their absorption, distribution, metabolism, and excretion, as well as their mechanisms of action within the body.

Pharmacological Treatment:

  • Bronchodilators: Medications such as albuterol may be used to open the airways and improve breathing.
  • Mucolytics: Drugs such as dornase alfa (Pulmozyme) help break down thick mucus in the lungs, making it easier to clear.
  • Antibiotics: Antibiotics are used to treat and prevent lung infections, which are common in individuals with cystic fibrosis.
  • CFTR modulators: These drugs target specific defects in the CFTR protein, helping improve chloride transport and reduce mucus buildup in the lungs.

Non-Pharmacological Treatment:

  • Airway clearance techniques: Techniques such as chest physiotherapy, percussion, and vibration help loosen and remove mucus from the airways.
  • Nutritional support: A high-calorie, high-protein diet and pancreatic enzyme supplements are essential for individuals with cystic fibrosis to maintain adequate nutrition and growth.
  • Lung transplant: In severe cases of cystic fibrosis with advanced lung disease, lung transplantation may be considered as a treatment option.